BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24387319)

  • 1. Metabolic phenotypes in primary unknown metastatic carcinoma.
    Kim HM; Kim DH; Jung WH; Koo JS
    J Transl Med; 2014 Jan; 12():2. PubMed ID: 24387319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-specific metabolic phenotypes in metastatic breast cancer.
    Kim HM; Jung WH; Koo JS
    J Transl Med; 2014 Dec; 12():354. PubMed ID: 25496516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of metabolism-related proteins in triple-negative breast cancer.
    Kim MJ; Kim DH; Jung WH; Koo JS
    Int J Clin Exp Pathol; 2014; 7(1):301-12. PubMed ID: 24427351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism-related proteins are differentially expressed according to the molecular subtype of invasive breast cancer defined by surrogate immunohistochemistry.
    Choi J; Jung WH; Koo JS
    Pathobiology; 2013; 80(1):41-52. PubMed ID: 22832328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of metabolism-related proteins in lacrimal gland adenoid cystic carcinoma.
    Koo JS; Yoon JS
    Am J Clin Pathol; 2015 Apr; 143(4):584-92. PubMed ID: 25780012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic phenotypes in triple-negative breast cancer.
    Kim S; Kim DH; Jung WH; Koo JS
    Tumour Biol; 2013 Jun; 34(3):1699-712. PubMed ID: 23443971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic interaction between cancer cells and stromal cells according to breast cancer molecular subtype.
    Choi J; Kim DH; Jung WH; Koo JS
    Breast Cancer Res; 2013; 15(5):R78. PubMed ID: 24020991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A preliminary study on the relationship between GLUT-1,MCT-4 and CAⅨ in laryngeal squamous cell carcinoma].
    Wang YB; Xu O; Zhang RJ; Shan CG
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Apr; 31(7):510-514;519. PubMed ID: 29871299
    [No Abstract]   [Full Text] [Related]  

  • 9. The expression of metabolism-related proteins in phyllodes tumors.
    Kwon JE; Jung WH; Koo JS
    Tumour Biol; 2013 Feb; 34(1):115-24. PubMed ID: 22986897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cancer-associated fibroblast related proteins in metastatic breast cancer: an immunohistochemical analysis.
    Kim HM; Jung WH; Koo JS
    J Transl Med; 2015 Jul; 13():222. PubMed ID: 26163388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycolysis-related protein expression in thyroid cancer.
    Nahm JH; Kim HM; Koo JS
    Tumour Biol; 2017 Mar; 39(3):1010428317695922. PubMed ID: 28347233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-related protein expression and its clinicopathologic implication in carcinoma of unknown primary.
    Koo JS; Kim H
    Tumour Biol; 2011 Oct; 32(5):893-904. PubMed ID: 21598042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic phenotypes in pancreatic cancer.
    Yu M; Zhou Q; Zhou Y; Fu Z; Tan L; Ye X; Zeng B; Gao W; Zhou J; Liu Y; Li Z; Lin Y; Lin Q; Chen R
    PLoS One; 2015; 10(2):e0115153. PubMed ID: 25719198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Hypoxia-inducible factor-1 α , glucose transporter-1, (GLUT-1) and carbon anhydrase IX in endometrial cancer patients.
    Sadlecki P; Bodnar M; Grabiec M; Marszalek A; Walentowicz P; Sokup A; Zegarska J; Walentowicz-Sadlecka M
    Biomed Res Int; 2014; 2014():616850. PubMed ID: 24745019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of intrinsic hypoxia markers HIF1alpha and CA-IX predict for local recurrence in stage T1-T2 glottic laryngeal carcinoma treated with radiotherapy.
    Schrijvers ML; van der Laan BF; de Bock GH; Pattje WJ; Mastik MF; Menkema L; Langendijk JA; Kluin PM; Schuuring E; van der Wal JE
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):161-9. PubMed ID: 18722267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of succinate dehydrogenase subunit B (SDHB) as a prognostic factor in advanced ileal well-differentiated neuroendocrine tumors.
    Milione M; Maisonneuve P; Pellegrinelli A; Pusceddu S; Centonze G; Dominoni F; Brambilla C; Rubino M; Faggiano A; Buzzoni R; Concas L; Giacomelli L; Coppa J; Mazzaferro V; de Braud F
    Endocrine; 2017 Sep; 57(3):512-517. PubMed ID: 27905048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON.
    Jonathan RA; Wijffels KI; Peeters W; de Wilde PC; Marres HA; Merkx MA; Oosterwijk E; van der Kogel AJ; Kaanders JH
    Radiother Oncol; 2006 Jun; 79(3):288-97. PubMed ID: 16730088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression and prognostic significance of GLUT1 according to histologic type of non-small-cell lung cancer and its association with volume-dependent parameters.
    Koh YW; Lee SJ; Park SY
    Lung Cancer; 2017 Feb; 104():31-37. PubMed ID: 28212997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose metabolism in NSCLC is histology-specific and diverges the prognostic potential of 18FDG-PET for adenocarcinoma and squamous cell carcinoma.
    Schuurbiers OC; Meijer TW; Kaanders JH; Looijen-Salamon MG; de Geus-Oei LF; van der Drift MA; van der Heijden EH; Oyen WJ; Visser EP; Span PN; Bussink J
    J Thorac Oncol; 2014 Oct; 9(10):1485-93. PubMed ID: 25170642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal expression of hypoxia regulated proteins is an adverse prognostic factor in colorectal carcinomas.
    Cleven AH; van Engeland M; Wouters BG; de Bruïne AP
    Cell Oncol; 2007; 29(3):229-40. PubMed ID: 17452775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.